Aspergillosis

• CLINICAL_TRIALS withdrawal · 2015-10-27
  Clinical Trial Update: UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients

  A non-interventional observational trial (NCT01622595) evaluating infectious complications in cancer patients sponsored by the University of…

• CLINICAL_TRIALS withdrawal · 2015-09-02
  Clinical Trial Update: A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis [Phase 4]

  This Phase 4 trial evaluating voriconazole plus micafungin versus voriconazole alone for invasive aspergillosis has been withdrawn.

• EMA withdrawal · 2009-08-04
  EMA Lapsed: Posaconazole SP (posaconazole) — Schering-Plough Europe

  EMA status shows Posaconazole SP has lapsed; therapeutic areas include candidiasis, mycoses, coccidioidomycosis, and aspergillosis.